Gender-specific association of oxidative stress and inflammation with cardiovascular risk factors in Arab population

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Khadir, Abdelkrim ^a   Tiss, Ali ^a   Kavalakatt, Sina ^a   Behbehani, Kazem ^a   Dehbi, Mohammed ^b   Elkum, Naser ^c  

^a DASMAN DIABETES INSTITUTE   (Kuwait)

^b HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

^c SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRY; ARAB; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLITE; OBESITY; OXIDATIVE STRESS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; ABDOMINAL OBESITY; ETHNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; ANTHROPOMETRY; ARABS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84928253862     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/512603     Document Type: Article

References (50)

1. W. B. Kannel, P. W. F. Wilson, B.-H. O. Nam, and R. B. D'Agostino, "Risk stratification of obesity as a coronary risk factor," The American Journal of Cardiology, vol. 90, no. 7, pp. 697-701, 2002.
2. S. Al Zenki, H. Al Omirah, S. Al Hooti et al., "High prevalence of metabolic syndrome among Kuwaiti adults-a wake-up call for public health intervention," International Journal of Environmental Research and Public Health, vol. 9, no. 5, pp. 1984-1996, 2012.
3. D. R. Whiting, L. Guariguata,C. Weil, and J. Shaw, "IDFdiabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030," Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311-321, 2011.
4. M. Alarouj, A. Bennakhi, Y. Alnesef,M. Sharifi, and N. Elkum, "Diabetes and associated cardiovascular risk factors in the State of Kuwait: the first national survey," International Journal of Clinical Practice, vol. 67, no. 1, pp. 89-96, 2013.
5. J.-P. Després, "Abdominal obesity and cardiovascular disease: is inflammation the missing link" Canadian Journal of Cardiology, vol. 28, no. 6, pp. 642-652, 2012.
6. D. P. Hajjar and A. M. Gotto Jr., "Biological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases," The American Journal of Pathology, vol. 182, no. 5, pp. 1474-1481, 2013.
7. G. Egger and J. Dixon, "Beyond obesity and lifestyle: a review of 21st century chronic disease determinants," BioMed Research International, vol. 2014,Article ID 731685, 12 pages, 2014.
8. J. V. Higdon and B. Frei, "Obesity and oxidative stress: a direct link to CVD" Arteriosclerosis,Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 365-367, 2003.
9. V. Cachofeiro, M. Goicochea, S. G. de Vinuesa, P. Oubina, V. Lahera, and J. Luno, "Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease," Kidney International Supplements, no. 111, pp. S4-S9, 2008.
10. M. El Assar, J. Angulo, and L. Rodrguez-Mañas, "Oxidative stress and vascular inflammation in aging," Free Radical Biology and Medicine, vol. 65, pp. 380-401, 2013.
11. M. Efrat and M. Aviram, "Paraoxonase 1 interactions withHDL, antioxidants and macrophages regulate atherogenesis-a protective role for HDL phospholipids," Advances in Experimental Medicine and Biology, vol. 660, pp. 153-166, 2010.
12. L. G. Costa, A. Vitalone, T. B. Cole, and C. E. Furlong, "Modulation of paraoxonase (PON1) activity," Biochemical Pharmacology, vol. 69, no. 4, pp. 541-550, 2005.
13. D. L. Feairheller, J.-Y. Park, K. M. Sturgeon et al., "Racial differences in oxidative stress and inflammation: in vitro and in vivo," Clinical and Translational Science, vol. 4, no. 1, pp. 32-37, 2011.
14. C. Vassalle, T. Simoncini, P. Chedraui, and F. R. Pérez-López, "Why sex matters: the biological mechanisms of cardiovascular disease,"Gynecological Endocrinology, vol. 28,no. 9, pp. 746-751, 2012.
15. M. A. Miller and F. P. Cappuccio, "Ethnicity and inflammatory pathways-implications for vascular disease, vascular risk and therapeutic intervention," CurrentMedicinal Chemistry, vol. 14, no. 13, pp. 1409-1425, 2007.
16. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, "Homeostasis model assessment: insulin resistance and-cell function from fasting plasma glucose and insulin concentrations in man," Diabetologia, vol. 28, no. 7, pp. 412-419, 1985.
17. P. A. Harris, R. Taylor, R. Thielke, J. Payne, N. Gonzalez, and J. G. Conde, "Research electronic data capture (REDCap)- a metadata-driven methodology and workflow process for providing translational research informatics support," Journal of Biomedical Informatics, vol. 42, no. 2, pp. 377-381, 2009.
18. A. Cartier, M. ɤoté, I. Lemieux et al., "Sex differences in inflammatory markers: what is the contribution of visceral adiposity" The American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1307-1314, 2009.
19. S. H. Wu, X. O. Shu, W. H. Chow et al., "Adiposity and fat distribution in relation to inflammation and oxidative stress in a relatively lean population of Chinese women," DiseaseMarkers, vol. 34, no. 4, pp. 279-293, 2013.
20. A. Farooq, W. L. Knez, K. Knez, A. Al-Noaimi, J. Grantham, and V. Mohamed-Ali, "Gender differences in fat distribution and inflammatory markers among arabs," Mediators of Inflammation, vol. 2013,Article ID 497324, 7 pages, 2013.
21. D. R. Brenner, K. Tepylo, K. M. Eny, L. E. Cahill, and A. El-Sohemy, "Comparison of bodymass index and waist circumference as predictors of cardiometabolic health in a population of young Canadian adults," Diabetology and Metabolic Syndrome, vol. 2, no. 1, article 28, 2010.
22. K. M. Pou, J. M. Massaro, U. Hoffmann et al., "Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the FraminghamHeart Study," Circulation, vol. 116, no. 11, pp. 1234-1241, 2007.
23. L. G. H. Goh, S. S. Dhaliwal, T. A. Welborn, A. H. Lee, and P. R. Della, "Ethnicity and the association between anthropometric indices of obesity and cardiovascular risk in women: a crosssectional study," BMJ Open, vol. 4, no. 5, Article ID e004702, 2014.
24. S. Gariballa, M. Kosanovic, J. Yasin, and A. Essa, "Oxidative damage and inflammation in obese diabetic emirati subjects," Nutrients, vol. 6, no. 11, pp. 4872-4880, 2014.
25. M. Barylski, D. P. Mikhailidis, M. Ciebiada, J. Rysz, and M. Banach, "Gender differences in the treatment of ischemic heart disease," Current PharmaceuticalDesign, vol. 17,no. 11,pp. 1059-1069, 2011.
26. K. Gundogan, F. Bayram, V. Gedik et al., "Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults," Archives ofMedical Science, vol. 9, no. 2, pp. 243-253, 2013.
27. M. M. Sirdah, A. S. Abu Ghali, and N. A. Al Laham, "The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians," Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 6, no. 1, pp. 4-8, 2012.
28. A. E. Staiano, B. A. Reeder, S. Elliott et al., "Body mass index versus waist circumference as predictors of mortality in Canadian adults," International Journal of Obesity, vol. 36, no. 11, pp. 1450-1454, 2012.
29. R. P. Wildman,D. Gu, K. Reynolds, X. Duan, X. Wu, and J. He, "Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults" The American Journal of Clinical Nutrition, vol. 82, no. 6, pp. 1195-1202, 2005.
30. H. Bays, "Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction," Current Opinion in Endocrinology & Diabetes and Obesity, vol. 21, no. 5, pp. 345-351, 2014.
31. T. Fukui,K. Yamauchi,M. Maruyama,T. Yasuda,M. Kohno, and Y. Abe, "Significance of measuring oxidative stress in lifestylerelated diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects," Hypertension Research, vol. 34, no. 9, pp. 1041-1045, 2011.
32. A. A. Miller, T. M. De Silva, K. A. Jackman, and C. G. Sobey, "Effect of gender and sex hormones on vascular oxidative stress," Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 10, pp. 1037-1043, 2007.
33. P. M. Ridker, "Clinical application of C-reactive protein for cardiovascular disease detection and prevention," Circulation, vol. 107, no. 3, pp. 363-369, 2003.
34. H. Hirose, H. Kawabe, N. Komiya, and I. Saito, "Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population," Journal of Atherosclerosis and Thrombosis, vol. 16, no. 2, pp. 77-82, 2009.
35. N. Sakano, D.-H. Wang, N. Takahashi et al., "Oxidative stress biomarkers and lifestyles in Japanese healthy people," Journal of Clinical Biochemistry and Nutrition, vol. 44, no. 2, pp. 185-195, 2009.
36. C. Marie, "Sex differences in cardiovascular disease and hypertension: involvement of the renin-angiotensin system," Hypertension, vol. 46, no. 3, pp. 475-476, 2005.
37. E. Barrett-Connor, "Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture," Circulation, vol. 95, no. 1, pp. 252-264, 1997.
38. A. El-Menyar, M. Zubaid, W. Rashed et al., "Comparison of men and women with acute coronary syndrome in six Middle Eastern countries,"TheAmericanJournal of Cardiology, vol. 104, no. 8, pp. 1018-1022, 2009.
39. N. M. Shara, "Cardiovascular disease in Middle Eastern women," Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 6, pp. 412-418, 2010.
40. J. K. Pai, T. Pischon, J. Ma et al., "Inflammatory markers and the risk of coronary heart disease inmen and women," The New England Journal of Medicine, vol. 351, no. 25, pp. 2599-2610, 2004.
41. M. Straczkowski, S. Dzienis-Straczkowska, A. Stepieñ, I. Kowalska, M. Szelachowska, and I. Kinalska, "Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system," Journal of Clinical Endocrinology andMetabolism, vol. 87,no. 10,pp. 4602-4606, 2002.
42. D. Gasevic, J. Frohlich, G. B. Mancini, and S. A. Lear, "Clinical usefulness of lipid ratios to identify men and women with metabolic syndrome: a cross-sectional study," Lipids in Health and Disease, vol. 13, no. 1, article 159, 2014.
43. A. Otocka-Kmiecik, D. P. Mikhailidis, S. J. Nicholls, M. Davidson, J. Rysz, and M. Banach, "Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease" Progress in Lipid Research, vol. 51, no. 4, pp. 314-324, 2012.
44. J. A. van Diepen, J. F. P. Berbée, L. M. Havekes, and P. C. N. Rensen, "Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis," Atherosclerosis, vol. 228, no. 2, pp. 306-315, 2013.
45. L. L. Roberson, E. C. Aneni, W. Maziak et al., "Beyond BMI: the 'metabolically healthy obese' phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality-a systematic review," BMC Public Health, vol. 14, no. 1, article 14, 2014.
46. C. M. Phillips, C. Dillon, J. M. Harrington et al., "Defining metabolically healthy obesity: role of dietary and lifestyle factors," PLoS ONE, vol. 8, no. 10, Article IDe76188, 2013.
47. M. Perreault, M. A. Zulyniak, F. Badoud et al., "A distinct fatty acid profile underlies the reduced inflammatory state of metabolically healthy obese individuals," PLoS ONE, vol. 9, no. 2, Article ID e88539, 2014.
48. C. Vassalle, L. Vigna, S. Bianchi et al., "Abiomarker of oxidative stress as a nontraditional risk factor in obese subjects," Biomarkers in Medicine, vol. 7, no. 4, pp. 633-639, 2013.
49. S. Bryan, B. Baregzay, D. Spicer, P. K. Singal, and N. Khaper, "Redox-inflammatory synergy in the metabolic syndrome," Canadian Journal of Physiology and Pharmacology, vol. 91, no. 1, pp. 22-30, 2013.
50. F. Razak, S. S. Anand, H. Shannon et al., "Defining obesity cut points in a multiethnic population," Circulation, vol. 115, no. 16, pp. 2111-2118, 2007.